Mettler-Toledo International, Inc. MTD

1,511.64 (7.51) (0.49%) as of 25 Sep
Market cap
$30.4B
P/E
33.9×
Indexes indicate stock being part of an index

Mettler-Toledo International, Inc. (MTD) EV/EBITDA

As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a EV/EBITDA of 24.9×. Over the past ten years it has ranged from 14.8× (October 2015) to 37.9× (December 2021); the current reading is higher than 61% of that period. That is in line with the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 24.8× 10.92%
FY2024 22.3× (6.02%)
FY2023 23.8× (15.37%)
FY2022 28.1× (24.17%)
FY2021 37.0× 14.87%
FY2020 32.2× 28.04%
FY2019 25.2× 27.85%
FY2018 19.7× (20.20%)
FY2017 24.7× 25.29%
FY2016 19.7× 12.70%

Quarterly

Period EV/EBITDA Change
Jun 2026 21.3× (3.86%)
Mar 2026 22.1× (10.68%)
Dec 2025 24.8× 11.76%
Sep 2025 22.2× 2.28%
42 more quarters

Against its own ten years

Low 14.8× High 37.9×
Ten-year median 23.8×
Current reading's percentile 61

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.7×
IQV IQVIA Holdings Inc. compare 17.3×
MTD Mettler-Toledo International, Inc. 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
A Agilent Technologies, Inc. compare 26.5×
ILMN Illumina, Inc. compare 36.0×
WAT Waters Corporation compare 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MTD